https://dailyexpose.uk/2022/01/11/mike-yeadon-the-variability-in-serious-adverse-events
“You should expect pharmaceutical mass manufacturers to be good at least one thing – and they are very good at this – consistent, high-quality, purity manufacturing [from] batch to batch to batch. They’re very good at this because that’s what their business is. They manufacture tablets, capsules, sprays and injections in the billions of doses … I trusted that these companies were doing what I knew they were very good at doing.
“And then, I stumbled across a couple of people who, independently, had been doing an analysis of the VAERS database.” Analysis of the VAERS database found 90% of adverse events were associated with less than 10% of the lots. “I remember seeing that [analysis] some months ago and I immediately knew the significance of it,” Dr. Mike Yeadon said.